Why COVID 'Razor Blade' Sore Throat Hurts So Bad
"This 'razor blade sore throat' was reported as a common symptom in China," where the variant first emerged in May, said Matthew S. Kelly, MD, MPH, chief of infectious diseases in the Pediatrics Department at the University of Arkansas for Medical Sciences. It's also been widely reported in other countries, including the U.S., as the variant has spread worldwide.
Why Does This Sore Throat Hurt So Much?
NB.1.8.1 – or Nimbus – is a subvariant of Omicron, the dominant COVID variant since late 2021. Omicron variants tend to cause more throat problems than the virus's earliest forms.
In the past few years, infectious disease specialist Peter Chin-Hong, MD, has seen more and more COVID patients with sore throats.
"Even before this variant, sore throat has been reported in up to 70% of patients with COVID, and it can be severe," said Chin-Hong, a professor at the University of California, San Francisco.
One possible explanation is that as the virus evolves, our body's response to it changes too.
COVID viruses bind to ACE2 receptors, found on the surface of cells. Cells in the upper airway (nose, throat) have more ACE2 receptors than those in the lower airway and lungs do – making them prime targets for Omicron variants, which bind to these receptors more strongly. Research suggests that of all the variants circulating now, Nimbus binds to ACE2 receptors the most.
Once the virus reaches those cell receptors in and around your throat, your immune system – likely primed by past infections, vaccination, or both – kicks into overdrive to keep the virus at bay. Cue inflammation, fluid buildup, redness, and swelling.
"Symptoms of the sore throat are not from the virus itself," said Chin-Hong. "They are from the inflammatory reaction to the virus."
Another possibility: A COVID sore throat might feel worse today than it did earlier in the pandemic, because the original virus had more severe systemic symptoms, diverting attention from individual ones like a sore throat, said Chin-Hong.
What Works for a Sore Throat?
Anti-inflammatory drugs."[Data shows that] the most effective thing for sore throat is systemic therapy," said Chin-Hong. Think over-the-counter pain relievers such as ibuprofen. If pill swallowing is painful, try a liquid form, he said.
Numbing agents, like throat sprays and lozenges with benzocaine, can be effective for short-term relief. Just don't ignore the package directions because misuse can be dangerous. "You're just trying to dull the pain for a couple of days when it's at its worst," said Kelly.
Menthol lozenges. Menthol affects nerve activity in the throat, causing a mild numbing effect for a short time.
Warm or cold liquids. No high-quality studies exist for these interventions, but many doctors still recommend hot tea and soup, or ice chips and ice pops. "This is sort of where medicine crosses over into: What seems to work for you? What did your mom do?" Kelly said.
Here's what not to do:
Don't beg your doctor for antibiotics. "Viruses are the most common cause of sore throat," said Chin-Hong – and antibiotics only work against bacterial infections. Plus: "Overprescribing antibiotics is bad for the microbiome and for increasing the risk of thrush and yeast infections."
Don't assume steroids are a quick fix. "Sometimes people try to reach for steroids for pain associated with sore throat," said Chin-Hong, but steroids can have an immune-suppressive effect. In one 2025 study, people who took a corticosteroid for mild or moderate COVID had longer-lasting symptoms than those who took a nonsteroidal anti-inflammatory instead. They were also more likely to be hospitalized.
Don't apply pressure. You may have seen TikTok influencers touting "throat massage" techniques for a sore throat. Your neck is rich with delicate blood vessels and tissues that can be easily damaged with too much pressure, Kelly said. Leave massaging to trained experts.
What Should You Do if You Have a Sore Throat?
Take an at-home COVID test. (They still work for new variants.) If the test is positive, you can ask your doctor whether you're a candidate for an antiviral medication to help you recover faster. If it's negative, retest in 24 hours to confirm. When throat pain is your only symptom, it can take a few days before nasal swab tests can detect the virus, said Chin-Hong.
Watch for symptoms that get worse, which could mean you have a severe bacterial infection or abscess. See a doctor if:
Throat pain is much worse, compared to other symptoms.
It's the worst sore throat you've ever had.
You notice signs of a throat obstruction, such as hoarseness, drooling, or trouble breathing.
Your doctor might do a throat culture for strep. If it's positive, you'll likely be prescribed antibiotics to keep the infection from spreading. "We want to prevent bad stuff down the road, like heart disease, rheumatic fever, or kidney disease," said Chin-Hong.
Should You Worry About Nimbus?
While U.S. cases are still relatively low, "this could lead to a summer surge or a surge in the next couple of months," said Kelly. Now's a good time to get a booster vaccine, particularly if you're 65 or older or have a chronic medical condition, he said. The COVID vaccines available now were formulated to target Omicron variants.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
2 minutes ago
- CBS News
Phillies ace Zack Wheeler undergoes thrombolysis surgery to remove blood clot in shoulder
Phillies ace Zack Wheeler underwent thrombolysis surgery Monday morning to remove a blood clot near his right shoulder. The Phillies said Wheeler had the procedure, performed by Dr. Paul DiMuzio, at Thomas Jefferson University Hospital. The club said Wheeler's timeline to return and further treatment options are to be determined. Wheeler, 35, was placed on the 15-day injured list Saturday night with a "right upper extremity blood clot." "It could have been a much more trying situation than it is," Phillies president of baseball operations Dave Dombrowski said Saturday. Wheeler started in Washington on Friday night, allowing two runs and four hits against the Nationals. He had been dealing with right shoulder soreness for over a month. After the game, Wheeler reported feeling a "little heaviness" in his shoulder, head athletic trainer Paul Buchheit said Saturday. Buchheit said Saturday that Wheeler's blood clot was independent of his previous stiffness. "He's an ace. He's the heart of this team, the heart of this staff," Phillies reliever Matt Strahm said Monday. "You never want to see it. He's a dad. His family comes first. That's what we worry about mostly." This is a developing story and will be updated.
Forbes
2 minutes ago
- Forbes
Measles Outbreak In Texas Officially Has Ended, But Threat Remains
The Texas Department of State Health Services announced on Monday that the measles outbreak in the western part of the state has ended. But officials also noted that the threat of new cases remains. And they reiterated that vaccination is the most effective means of preventing infections, reducing the severity of disease, and limiting extensive spread of the virus. The first cases associated with the current outbreak were reported in January 2025. In the ensuing seven months, 762 cases have been confirmed, resulting in 99 hospitalizations, and two deaths. About 30% of the cases occurred in children under 5 years of age. Over two-thirds occurred in people under 18 years of age. Only 21 of the 762 infected people are known to have received the recommended two-dose measles vaccine. Most of the cases occurred in the western part of the state, with 414 cases reported in Gaines County alone. But the virus spread far beyond this location. Linked cases have been reported in multiple Texas counties, New Mexico, Oklahoma, Kansas, Mexico and Canada. In all locations, most cases were in unvaccinated or under-vaccinated people. Measles is a highly contagious airborne disease. Infected people usually exhibit a high fever, respiratory symptoms, conjunctivitis and the tell-tale rash. This rash typically appears about 14 days after exposure to the virus. In some cases, the incubation period can be longer. Symptoms may not appear until 21 days after exposure. For this reason, infectious disease experts consider an outbreak to be over if no new cases are reported for 42 days or two incubation periods. Some people falsely consider measles to be a relatively benign disease. An unpleasant but not severe childhood illness, they might argue. But according to the CDC, about 20% of unvaccinated people in the U.S. who get measles require hospitalization. The disease is fatal in approximately one to three out of every 1,000 unvaccinated children. About one out of every 1,000 children will develop swelling of the brain, which can lead to long-term hearing and cognitive problems. And, according to the American College of Obstetricians and Gynecologists, measles infection during pregnancy can lead to increased risks of preterm delivery, low birth weight, and miscarriage. But measles can be prevented. The vaccine, typically administered in the U.S. as part of the measles mumps rubella shot, is safe and very effective. The numbers speak volumes. Let's consider its effectiveness. Prior to the introduction of the first measles vaccine in 1963, roughly half a million cases occurred in the U.S. every year. In 2023, only 47 cases were reported. And in all recent outbreaks, a vast majority of cases have occurred in unvaccinated people. Now let's consider safety. No studies have shown a link between the MMR vaccine and autism. And the MMR vaccine never has contained thimerosal or any other form of mercury. Although some people experience adverse reactions to this or other vaccines, the MMR vaccine is incredibly safe. The current measles outbreak officially has ended. That's the good news. But the threat still exists. Thus far in 2025, measles cases have been reported in 40 U.S. states and multiple countries throughout the world. And anytime an infected person interacts with unvaccinated people, spread can occur. As noted on the CDC website, 'Measles anywhere is a threat everywhere.'
Fast Company
31 minutes ago
- Fast Company
Philips CEO Jeff DiLullo on how AI is changing healthcare today
AI is quietly reshaping the efficiency, power, and potential of U.S. healthcare, even as government health policy and spending drastically shift. Philips, the legacy electronics manufacturer turned medtech provider, is leading the AI healthcare revolution, streamlining and accelerating the workflow of patient care. Philips North America CEO Jeff DiLullo shares how technology can have the biggest impact on health outcomes today—from radiology scans to cancer diagnoses, and what it takes for leaders in any industry to rethink the way we work to best meet the moment. This is an abridged transcript of an interview from Rapid Response, hosted by the former editor-in-chief of Fast Company Bob Safian. From the team behind the Masters of Scale podcast, Rapid Response features candid conversations with today's top business leaders navigating real-time challenges. Subscribe to Rapid Response wherever you get your podcasts to ensure you never miss an episode. AI seems to be changing everything. There's a lot of talk about it, but in some businesses, I feel like the conversation about it is ahead of the actual implementation or the impact, and I'm curious how true that might be in medtech. How is AI impacting things now, today, versus what you think it can do in the future? If you remember, we released the Future of Health Index. One of the things that we realized is that AI, in some of these compartments I'm talking about, is quite mature. FDA cleared, very safe for clinical use. Other areas, it's more experimental. But the trust factor of the use of that AI is actually quite nascent. It's the biggest barrier right now to larger scale deployment. Yeah. That health index that you mentioned, the 2025 Future Health Index, I mean, there was this sort of trust gap in it, right? That something like 60, 65% of clinicians trust AI, but only about a third of patients or certainly older patients do. How do you bridge that gap? Is it Philips's job to bridge that gap? Whose job is it? So I have the benefit of having two Gen Zs and a millennial, they are digitally fluid. They don't worry at all about the AI models that are coming on the other side of this because they're used to it and they understand it. Older patients, not so much. The magic is always the healthcare practitioner that's directly interfacing with the customers or the patients. If they believe what they're doing, if they know it's credible, if they're using it to augment their analysis or their diagnostics, not replacing it, I think ultimately we'll see an uplift. It's our job to provide valid FDA-cleared, very good diagnostic capability leveraging AI. But if our doctors and nurses believe what we're doing and they see the value in increasing their time with patients and also a little de-stressing, we think it's going to really pick up in a parabolic way in the next few years, at least in health. I can understand and see how AI can quickly help some of the back office functionality in healthcare, but you're talking about for practitioners, right? How does that practically work today? So I'm going to give you, let's talk radiology. It's the biggest field right now, diagnostic, right? The earlier the diagnostic, the better the outcome most likely. And when I think of a radiologist, I have to wait a month and a half. I'm in a pretty nice part of Vanderbilt University area, like a lot of health tech around me in Nashville, but I've got to wait over a month to get a scan. So in radiology, we start with the box or the design, right? I have an MRI that is highly efficient. I can move it around, I can put it on a truck. But today, I can get a scan done in half or even a third of the time. The AI built into the system software makes it much faster. Just a few months ago, I had a scan that took only 20 minutes—whereas a couple of years ago, the same scan would have taken about 45 minutes. The smart speed that we have on the system actually compresses the scanning time. It doesn't fill in the blanks, it removes the noise. You actually get a better scan in a shorter time. If you're a radiologist having to do 12 or 15 studies a day, but you can do 20 studies a day, I get more patients through, I drive more reimbursement, it's better for the hospital, it's better for patient care. Then I take it into workflow, and today I can pinpoint things that are happening in that digital image and send it to a radiologist and say, 'You should look here,' in just very simple speak. It's very complicated stuff, but the AI is already mainstream today where we can actually pinpoint areas for radiologists to look at and make a determination. I can digitize the whole process today with digital pathology. And I can have a finding where somebody's waiting, do I have cancer or not? I can do this in hours now because it's all digital. And that kind of workflow and orchestration is a game changer. And the issue of AI hallucinations, which show up with some of the generative AI things, does that apply to healthcare? Are there different kinds of safeguards? Because I guess there's a human who's checking. There's so many things today, like smart speed I just talked about, being able to run that radiology workflow to compress the time of diagnostics, run the tumor boards in hours, on-demand meetings like you and I would on Zoom or teams, all of that is happening today, but not happening at the pace it could. My point is, go do that right now. Every health system, go do that. As you start to unpack these more generative AI models, I think there's real reason to be cautious and make sure we have the right controls and the governance on them, but not experimenting in them also is not an option. We kind of have to. But we see leading institutions, MGB, Stanford, Mount Sinai in New York, we see them really working with population health data to really try to train models on very specific and even broad use cases. There's so much to do right now. In other words, you don't have to go all the way out to the silver bullet of, we're going to live forever or we're going to solve every health problem. You can make the system we have right now more efficient and more effective today. Bob, when you first drove a car, was the first thing you did to go to the Autobahn? Probably not. There's so much to do in the neighborhood. There's so much to do in my town that I can really get good at what we're doing and drive productivity at scale. You need to have the innovation and the creativity to get us to the next place, but 80% of it we can do today. That is just game-changing in terms of how we deliver today, and that's what we think is really the next opportunity here for healthcare. And I think that'll happen with what's mature in AI and virtual capabilities in the next few years because the need is so great.
